Nyhet -

Bioneer helps life science with R&D

The Contract Research Organisation Bioneer acts as an external R&D department for the life science ecosystem of companies involved in therapeutic development. The company is seeing substantial growth partly driven by its impressive journey as a specialty-CRO for recombinant protein solutions.

The specialty-CRO Bioneer has consolidated its role as R&D partner to the life science industry.

At the core of its activities, Bioneer translates science and know-how into technology platforms and processes that enable the industry to speed up discovery and development of new therapeutics.

”In essence, we help companies with two things: To create the necessary data to establish proof of concept for their compounds, and to produce recombinant proteins,” says Bioneer’s Chief Scientific Officer, Christian Clausen.

Bioneer in reality serves as an extended R&D department for its partners. The company makes its know-how, advanced disease models, technology platforms and laboratory facilities available to help produce, characterize and select the best drug candidates and the best formulations in the important R&D phases where multiple concepts are still being tried out.

”We are particularly proud of the role we play to Scandinavian biotech and pharmaceutical companies. We have worked alongside many of the biotech teams from they were first established, which is really optimal and gives us the ability to exchange ideas with their scientific experts and be part of the strategic choices they make,” says Christian Clausen.

The CSO explains that, although Bioneer has been the ‘go-to’ partner for all matters related to production of biologics and specialty proteins for more than three decades, the journey still continues.

”We have worked with so many challenging proteins over the years, most of which have been produced using our microbial platforms. Now we have expanded our capabilities and our laboratories to also handle production of more mainstream biologics using mammalian platforms,” says Christian Clausen.

Relaterade länkar

Ämnen

  • Ekonomi, finans

Kategorier

  • medicon valley life science

Regioner

  • Skåne

Kontakter

Relaterad media

  • Christian Clausen CSO Bioneer
    Licens:
    All rights reserved
    mer info...

Relaterat innehåll

  • Making the impossible possible

    Diagonal Bio AB (Diagonal) is a biotech company that seeks to do what was once thought impossible – create a universal diagnostic platform which is quick, accurate, cost-effective and able to test multiple samples in parallel. The company was founded in Medicon Village in Lund in 2020, with a vision to limit the spread of infectious disease world-wide.
    Diagonal plan to realise the vision by cr

  • The uniqueness of Medicon Valley Alliance

    Medicon Valley Alliance (MVA) is a non-profit membership organisation in the Danish-Swedish life science cluster Medicon Valley. They also have the distinction of being the only bi-national cluster region in the Nordics.
    All cluster formations within Life Science collaborate with other actors nationally and internationally, but MVA has built an entire life science cluster across two leading lif

  • Medeon Science Park continues its journey of expansion

    Medeon Science Park has a strong focus on the expansion that began over 18 months ago, and which now enables new establishments in the park. After a number of stages of new construction and remodelling, there is now space available for the successful growing companies expanding in the park, but also for completely new establishments.
    A stimulating business climate with an ideal location offers

Fyll i din epostadress för att följa Affärstidningen Näringsliv

När du väljer att skapa ett konto och följa ett nyhetsrum kommer dina personuppgifter behandlas av oss och av ägaren av nyhetsrummet för att du ska kunna motta nyheter och uppdateringar enligt dina bevakningsinställningar.

För att läsa mer om detta, var vänlig läs vår Integritetspolicy som berör vår behandling av dina personuppgifter, och Integritetspolicy för Contacts som berör behandlingen av dina personuppgifter från ägaren av nyhetsrummet du följer.

Vänligen notera att våra Användarvillkor gäller alla våra tjänster.

Du kan dra tillbaka ditt samtycke när som helst genom att avregistrera dig eller genom att ta bort ditt konto.
Kolla din inkorg

Mejl skickat till __email__. Klicka på länken i mejlet för att följa Affärstidningen Näringsliv.

Okej